BioSig Technologies, Inc. STEX Derivative, Gain (Loss) on Derivative, Net
Discontinued — last reported Q4 '25
Derivative, Gain (Loss) on Derivative, Net at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DerivativeGainLossOnDerivativeNet.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s derivative, gain (loss) on derivative, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s derivative, gain (loss) on derivative, net?
- BioSig Technologies, Inc. (STEX) reported derivative, gain (loss) on derivative, net of -$97.42M in Q4 2025.
- What does derivative, gain (loss) on derivative, net mean?
- This represents the net gain or loss resulting from changes in the fair value of derivative financial instruments used for hedging or speculative purposes. Because these instruments are often tied to market volatility, this metric highlights the company's exposure to external market fluctuations. It is a critical indicator for assessing the impact of financial engineering on the bottom line.